plasminogen

基本解釋

Conclusion The plasminogen ability is lower in women with PCOS.
結(jié)論P(yáng)COS患者的血纖溶能力較正常對(duì)照者有所下降。
We studied the mechanism of plasmaand tissue kallikreinin activating plasminogen.
作者研究了血漿和組織激肽釋放酶激活纖溶酶原的機(jī)制。
THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN ORAL SQUAMOUS CELL CARCINOMA.
尿激酶受體在口腔鱗癌中的表達(dá)。
Recombinant tissue-type plasminogen activator (r-TPA) was also used when clinically indicated.
臨床上有指征時(shí)也可應(yīng)用重組組織型纖溶酶原激活劑。
In this process, urokinase-type plasminogen activator(uPA) and P-selectin play a very important role .
在此過(guò)程中，尿激酶型纖溶酶原激活物(urokinase-type plasminogen activator，uPA)和P-選擇素起著十分重要的作用。